Home » ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate
ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate
ZymoGenetics has gotten back full commercial rights to its lead cancer drug in development.
Xconomy
Xconomy
Upcoming Events
-
07May
-
14May
-
30May